INCYTE CORPORATION Adjustment to Additional Paid in Capital, Income Tax Effect from Share-based Compensation, Net
INCYTE CORPORATION (INCY) reported Adjustment to Additional Paid in Capital, Income Tax Effect from Share-based Compensation, Net of $2.87 million for the 12-month period ending 2015-12-31, per its 10-K filed 2018-02-15.
Discontinued › Notes › Compensation Related Costs
us-gaap:AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet · last filed 2018-02-15
- INCYTE CORPORATION adjustment to additional paid in capital, income tax effect from share-based compensation, net for fiscal 2015 was $2.87M.
- INCYTE CORPORATION adjustment to additional paid in capital, income tax effect from share-based compensation, net for fiscal 2014 was -$22.00K, a 110.28% decline from fiscal 2013.
- INCYTE CORPORATION adjustment to additional paid in capital, income tax effect from share-based compensation, net for fiscal 2013 was $214.00K.
| Period end | Adjustment to Additional Paid in Capital, Income Tax Effect from Share-based Compensation, Net 12 month |
|---|---|
| 2015-12-31 | $2.87M 10-K · filed 2018-02-15 |
| 2014-12-31 | -$22.00K 10-K · filed 2017-02-14 |
| 2013-12-31 | $214.00K 10-K · filed 2016-02-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| IQVIA HOLDINGS INC. (IQV) | United States | $45.926B | 20.54 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |